Nidan Laboratories & Healthcare Ltd
₹ 32.5
-0.31%
26 Sep
- close price
About
Incorporated in 2000, Nidan Laboratories & Healthcare Ltd provides various Healthcare and Diagnostics Services[1]
Key Points
- Market Cap ₹ 45.2 Cr.
- Current Price ₹ 32.5
- High / Low ₹ 41.2 / 27.0
- Stock P/E
- Book Value ₹ 47.6
- Dividend Yield 0.00 %
- ROCE 7.95 %
- ROE -0.03 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.68 times its book value
Cons
- Promoter holding has decreased over last quarter: -5.75%
- The company has delivered a poor sales growth of 3.80% over past five years.
- Company has a low return on equity of 3.30% over last 3 years.
- Working capital days have increased from 226 days to 366 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 20.07 | 21.41 | 20.38 | 29.66 | 24.27 | 24.18 | |
| 12.23 | 13.78 | 11.49 | 20.25 | 17.47 | 17.74 | |
| Operating Profit | 7.84 | 7.63 | 8.89 | 9.41 | 6.80 | 6.44 |
| OPM % | 39.06% | 35.64% | 43.62% | 31.73% | 28.02% | 26.63% |
| 0.37 | 0.01 | 1.06 | 0.40 | 3.33 | -3.76 | |
| Interest | 4.75 | 3.74 | 3.46 | 2.66 | 2.22 | 2.18 |
| Depreciation | 3.24 | 3.19 | 3.18 | 2.63 | 3.10 | 2.87 |
| Profit before tax | 0.22 | 0.71 | 3.31 | 4.52 | 4.81 | -2.37 |
| Tax % | 0.00% | 0.00% | 30.21% | 41.15% | 26.40% | 36.29% |
| 0.22 | 0.71 | 2.30 | 2.66 | 3.54 | -3.23 | |
| EPS in Rs | 0.22 | 0.72 | 2.32 | 1.91 | 2.55 | -2.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 6% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | 3% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 9.90 | 9.90 | 9.90 | 13.90 | 13.90 | 13.90 |
| Reserves | 0.41 | 1.13 | 3.43 | 52.00 | 55.54 | 52.31 |
| 32.16 | 34.35 | 38.04 | 19.29 | 10.93 | 12.44 | |
| 0.58 | -0.17 | 2.37 | 3.29 | 4.03 | 3.90 | |
| Total Liabilities | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 |
| 23.28 | 20.10 | 19.92 | 20.46 | 21.39 | 17.95 | |
| CWIP | 0.00 | 0.00 | 0.23 | 3.81 | 0.00 | 0.04 |
| Investments | 0.53 | 0.53 | 0.27 | 0.00 | 0.00 | 0.00 |
| 19.24 | 24.58 | 33.32 | 64.21 | 63.01 | 64.56 | |
| Total Assets | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 8.95 | 4.62 | 4.35 | 7.83 | 10.97 | -14.93 | |
| 1.00 | -0.01 | -3.22 | -35.74 | -0.29 | 9.84 | |
| -5.81 | -1.56 | -1.22 | 28.72 | -10.37 | -0.49 | |
| Net Cash Flow | 4.14 | 3.05 | -0.10 | 0.80 | 0.32 | -5.57 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Debtor Days | 102.03 | 92.57 | 97.25 | 65.96 | 90.69 | 7.85 |
| Inventory Days | 16.98 | 12.88 | 18.17 | 25.99 | ||
| Days Payable | 116.72 | -25.76 | 213.05 | 135.84 | ||
| Cash Conversion Cycle | 2.29 | 131.22 | -97.64 | -43.89 | 90.69 | 7.85 |
| Working Capital Days | 256.25 | 291.69 | 238.56 | 176.10 | 136.10 | 366.06 |
| ROCE % | 10.13% | 13.99% | 10.09% | 8.17% | 7.95% |
Documents
Announcements
-
Resignation
3 September 2024 - Nidan Laboratories And Healthcare Limited has informed regarding Resignation of Ms Kunika Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. September 03, …
-
Book Closure
3 September 2024 - Register of Members & Share Transfer Books of the Company will remain closed from 21-Sep-2024 to 27-Sep-2024 for the purpose of Meeting.
-
Shareholders meeting
3 September 2024 - Nidan Laboratories And Healthcare Limited has informed regarding Notice of Annual General Meeting to be held on September 27, 2024
-
Outcome of Board Meeting
20 August 2024 - Nidan Laboratories And Healthcare Limited has informed regarding Board meeting held on August 20, 2024.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
12 July 2024 - Nidan Laboratories And Healthcare Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
History[1]
Nidan was established in 2000 by Dr. Nitin Thorve and Mrs. Roshan Thorve. The company runs 35 diagnostic centres across greater Mumbai. Nidan operates its centres through the brand named 'Nidan Diagnostics’ and offers services including CT scan, MRI, Ultra Sound, 2D Echo, ECG, etc. The company is listed on NSE.